001     156026
005     20240322115503.0
024 7 _ |a 10.1007/s00249-021-01515-7
|2 doi
024 7 _ |a pmid:33782728
|2 pmid
024 7 _ |a pmc:PMC8071794
|2 pmc
024 7 _ |a 0175-7571
|2 ISSN
024 7 _ |a 0340-1057
|2 ISSN
024 7 _ |a 1432-1017
|2 ISSN
024 7 _ |a altmetric:103009635
|2 altmetric
037 _ _ |a DZNE-2021-01158
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Najbauer, Eszter E
|b 0
245 _ _ |a Structure, gating and interactions of the voltage-dependent anion channel.
260 _ _ |a New York
|c 2021
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1711017989_32502
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The voltage-dependent anion channel (VDAC) is one of the most highly abundant proteins found in the outer mitochondrial membrane, and was one of the earliest discovered. Here we review progress in understanding VDAC function with a focus on its structure, discussing various models proposed for voltage gating as well as potential drug targets to modulate the channel's function. In addition, we explore the sensitivity of VDAC structure to variations in the membrane environment, comparing DMPC-only, DMPC with cholesterol, and near-native lipid compositions, and use magic-angle spinning NMR spectroscopy to locate cholesterol on the outside of the β-barrel. We find that the VDAC protein structure remains unchanged in different membrane compositions, including conditions with cholesterol.
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Electrophysiology
|2 Other
650 _ 7 |a Magic-angle spinning
|2 Other
650 _ 7 |a Membrane protein
|2 Other
650 _ 7 |a Molecular dynamics simulations
|2 Other
650 _ 7 |a Solid-state NMR
|2 Other
650 _ 7 |a Voltage dependent anion channel
|2 Other
650 _ 2 |a Ion Channel Gating
|2 MeSH
650 _ 2 |a Molecular Dynamics Simulation
|2 MeSH
650 _ 2 |a Voltage-Dependent Anion Channels: chemistry
|2 MeSH
650 _ 2 |a Voltage-Dependent Anion Channels: metabolism
|2 MeSH
700 1 _ |a Becker, Stefan
|b 1
700 1 _ |a Giller, Karin
|b 2
700 1 _ |a Zweckstetter, Markus
|0 P:(DE-2719)2810591
|b 3
|u dzne
700 1 _ |a Lange, Adam
|b 4
700 1 _ |a Steinem, Claudia
|b 5
700 1 _ |a de Groot, Bert L
|b 6
700 1 _ |a Griesinger, Christian
|b 7
700 1 _ |a Andreas, Loren B
|0 0000-0003-3216-9065
|b 8
773 _ _ |a 10.1007/s00249-021-01515-7
|g Vol. 50, no. 2, p. 159 - 172
|0 PERI:(DE-600)1398349-0
|n 2
|p 159 - 172
|t European biophysics journal
|v 50
|y 2021
|x 1432-1017
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/156026/files/DZNE-2021-01158.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/156026/files/DZNE-2021-01158.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:156026
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2810591
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-30
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR BIOPHYS J BIOPHY : 2021
|d 2022-11-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-30
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-30
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2021-01-30
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-30
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2022-11-30
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-30
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-30
920 1 _ |0 I:(DE-2719)1410001
|k AG Zweckstetter
|l Translational Structural Biology
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1410001
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21